Exozymes (EXOZ) Accounts Payables (2023 - 2026)
Exozymes (EXOZ) posted quarterly Accounts Payables of $1.2 million for Q4 2025, up 33.66% year-over-year from $924252.0 in Q4 2024, and up 36.6% quarter-over-quarter from $904353.0 in Q3 2025.
Exozymes (EXOZ) Accounts Payables (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Accounts Payables for 3 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables rose 33.66% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 33.66% YoY), while the FY2025 annual figure was $1.2 million, up 33.66% from the prior year.
- Accounts Payables improved to $1.2 million in Q4 2025 per EXOZ's latest filing, from $904353.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.2 million in Q4 2025 and bottomed at $702911.0 in Q4 2023.
- Historically, Accounts Payables has averaged $953984.3 across 3 years, with a median of $924252.0 in 2024.
- On a YoY basis, Accounts Payables climbed as much as 33.66% in 2025 and fell as far as 0.47% in 2025.
- Exozymes' Accounts Payables stood at $702911.0 in 2023, then soared by 31.49% to $924252.0 in 2024, then jumped by 33.66% to $1.2 million in 2025.
- Business Quant data shows EXOZ's Accounts Payables at $1.2 million in Q4 2025, $904353.0 in Q3 2025, and $930629.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 35.57 Mn |
| 10 | Exozymes | 64.95 Mn | 64.95 Mn | - | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 904,353.00 |
| Jun 30, 2025 | 930,629.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 924,252.00 |
| Sep 30, 2024 | 908,606.00 |
| Dec 31, 2023 | 702,911.00 |